查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球伤口敷料市场 - 2023-2030
市场调查报告书
商品编码
1373377

全球伤口敷料市场 - 2023-2030

Global Wound Dressing Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 183 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

伤口敷料清洁、覆盖并保护伤口免受外部环境的影响。它必须提供潮湿的环境，去除多余的渗出物，避免浸渍，保护损伤免受感染，并保持足够的气体交换。

选择伤口敷料是为了控制渗出物、保护伤口和缓解疼痛。敷料或敷料是敷在伤口上的无菌垫，可促进癒合并保护伤口免受进一步伤害。现代敷料包括干燥或浸渍纱布、塑胶薄膜、凝胶、泡沫、水胶体、藻酸盐、水凝胶和多醣糊剂、颗粒和珠子。

市场动态：驱动因素与限制因素

与伤口敷料相关的研究和投资活动不断增加

公司为提供先进的伤口敷料和伤口护理而增加的投资预计将推动市场成长。新产品上市和批准的增加预计也将推动市场成长。

例如，2023 年 5 月 24 日，伤口管理公司 RedDress 在 D 轮融资中筹集了 2,600 万美元，以继续开发利用人体血液启动伤口癒合过程的技术。本轮融资由 ATHOS Biopharma GmbH 等投资者参与，使该公司的总资金达到 4,300 万美元。

此外，2021 年 5 月 14 日，Healogics 发布了一项新的 2.4 亿美元股权投资，使该公司能够继续发展成为以患者为中心的领先伤口护理中心营运商。

克制

与伤口敷料相关的高成本

先进伤口敷料的高成本预计将阻碍市场成长。压疮治疗的直接费用在 2,000 美元到 20,000 美元之间。

有关此报告的更多详细资讯 - 索取样品

目录

第 1 章：方法与范围

  • 研究方法论
  • 报告的研究目的和范围

第 2 章：定义与概述

第 3 章：执行摘要

  • 按产品类型分類的片段
  • 按材料类型分類的片段
  • 按伤口类型分類的片段
  • 最终使用者的片段
  • 按地区分類的片段

第 4 章：动力学

  • 影响因素
    • 司机
      • 与伤口敷料相关的研究和投资活动不断增加
      • YY
    • 限制
      • 与伤口敷料相关的高成本
    • 机会
    • 影响分析

第 5 章：产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • 俄乌战争影响分析
  • DMI 意见

第 6 章：COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆发前的情景
    • 新冠疫情期间的情景
    • 新冠疫情后的情景
  • COVID-19 期间的定价动态
  • 供需谱
  • 疫情期间政府与市场相关的倡议
  • 製造商策略倡议
  • 结论

第 7 章：按产品类型

  • 传统伤口敷料
    • 纱布敷料
    • 皮棉
    • 膏药
    • 绷带
    • 棉绒
  • 现代伤口敷料
    • 被动产品
    • 互动产品
    • 生物活性产品
    • 生物活性伤口敷料
    • 组织工程皮肤替代品
    • 药敷料
    • 复合敷料

第 8 章：依材料类型

  • 亲水胶体
  • 水凝胶
  • 胶原
  • 海藻酸盐
  • 泡棉
  • 透明的
  • 布

第 9 章：按伤口类型

  • 慢性伤口
    • 糖尿病足溃疡
    • 压疮
    • 静脉溃疡
    • 其他的
  • 急性伤口
    • 手术伤口
    • 外伤
    • 伯恩斯

第 10 章：最终用户

  • 医院
  • 专科诊所
  • 研究机构
  • 创伤中心
  • 社区保健中心
  • 其他的

第 11 章：按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 亚太其他地区
  • 中东和非洲

第 12 章：竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 13 章：公司简介

  • Abbott Laboratories
    • 公司简介
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • BioMerieux SA
  • EKF Diagnostics Holdings plc
  • Atlas Medical
  • Quidel Corporation
  • BIOSYNEX SA
  • NG BIOTECH SAS
  • Axis Medicare
  • Cardinal Health Inc.
  • Thermo Fisher Scientific Inc.

第 14 章：附录

简介目录
Product Code: PH1870

Overview

Wound dressings clean, cover, and protect the wound from the external environment. It must provide a moist environment, remove excess exudate, avoid maceration, protect the damage from infection, and maintain an adequate exchange of gases.

Wound dressings are chosen to address exudate control, wound protection, and pain relief. A dressing or compress is a sterile pad applied to a wound to promote healing and protect the wound from further harm. Modern dressings include dry or impregnated gauze, plastic films, gels, foams, hydrocolloids, alginates, hydrogels, and polysaccharide pastes, granules, and beads.

Market Dynamics: Drivers & Restraints

Rising research & investment activities related to wound dressing

The increase in the investments by the companies in order to provide advanced wound dressing and wound care is expected to drive market growth. The increase in the product launches and approvals of the new products is also expected to drive the market growth.

For instance, on May 24, 2023, Wound management company RedDress raised $26m in a Series D financing round to continue developing its technology that harnesses human blood to jump-start the wound healing process. The round, which received participation from investors including ATHOS Biopharma GmbH, brings the company's total funding to $43m.

Additionally, on May 14, 2021, Healogics released a new $240 million equity investment, positioning the Company to continue its growth as a leading patient-centric wound care center operator.

Restraint

High costs associated with the wound dressings

The high cost associated with advanced wound dressing is expected to hamper the market growth. The direct costs for pressure ulcer treatment range between $2,000 and $20,000.

For more details on this report - Request for Sample

Segment Analysis

The global wound dressing market is segmented based on product type, material type, wound type, end-user and region.

Chronic wounds segment accounted for 45.3% of the market share

Chronic wounds segment is expected to hold a significant position in the market position. The increase in chronic wound burdens such as diabetic ulcers, nonhealing surgical wounds, burns, and venous-related ulcerations is expected to increase the demand for wound dressing and thus increase segment growth.

For instance, according to the report issued by Mission Regional Medical Center in 2022, more than 29 million people (9.5% of the population) have diabetes in the United States (US) and almost two million of those people annually will develop a diabetic foot ulcer or other non-healing wound.

Additionally, according to the report by the National Institute of Health in 2023, over 6.7 million people in the United States alone suffer from chronic nonhealing wounds including diabetic ulcers, nonhealing surgical wounds, burns, and venous-related ulcerations.

Geographical Analysis

North America is expected to hold a significant position in the global wound dressing market share

North American region accounted for the largest market share. The increase in the number of product launches, the presence of the major players in the region, and improved healthcare infrastructure in the region are expected to hold the region in the dominant market share.

For instance, on December 8, 2022, NEXGEL Inc. launched a unique hydrogel dressing, called Turfguard, for treating painful turf burns and protecting sports-related wounds.

Additionally, on August 11, 2022, DrySee launched a patented waterproof bandage with a liquid intrusion alert to users and caregivers when water or other liquids have penetrated the bandage. Thus, introducing new products and approvals is expected to drive the market growth in the region.

COVID-19 Impact Analysis:

COVID-19 pandemic was expected to lower the use of advanced wound dressing, as they require healthcare advice, thereby restricting the market's growth. The disruption in the supply chains and closure of the hospitals have affected the market growth negatively.

Competitive Landscape

The leading companies with a significant market share include: 3M Company, Dukal Corporation, Integra Lifesciences Holdings Corporation, Medline Industries Inc., Mckesson Corporation, Acelity L.P. Inc., Molnlycke Health Care, Coloplast Corp., Argentum Medical LLC, Urgo Medical among others.

Key Developments

  • On 3 January 2023, Convatec launched ConvaFoam, a family of advanced foam dressings designed to address the needs of healthcare providers and their patients.
  • On October 18, 2023, DuPont launched a new soft skin adhesive for wound care dressings. The non-sensitizing, non-irritating, and non-cytotoxic adhesive helps to protect the highly sensitive and fragile skin.

Why Purchase the Report?

  • To visualize the global wound dressing market segmentation based on product type, material type, wound type, end-user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of wound dressing market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global wound dressing market report would provide approximately 69 tables, 71 figures, and 183 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Material Type
  • 3.3. Snippet by Wound Type
  • 3.4. Snippet by End-User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising research & investment activities related to wound dressing
      • 4.1.1.2.
    • 4.1.2. Restraints
      • 4.1.2.1. High costs associated with the wound dressings
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Traditional Wound Dressing *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 7.2.3. Gauze Dressing
    • 7.2.4. Lint
    • 7.2.5. Plasters
    • 7.2.6. Bandages
    • 7.2.7. Cotton Wool
  • 7.3. Modern Wound Dressing
    • 7.3.1. Passive Products
    • 7.3.2. Interactive Products
    • 7.3.3. Bioactive Products
    • 7.3.4. Bioactive Wound Dressing
    • 7.3.5. Tissue-Engineered Skin Substitutes
    • 7.3.6. Medicated Dressing
    • 7.3.7. Composite Dressing

8. By Material Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 8.1.2. Market Attractiveness Index, By Material Type
  • 8.2. Hydrocolloid *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Hydrogel
  • 8.4. Collagen
  • 8.5. Alginate
  • 8.6. Foam
  • 8.7. Transparent
  • 8.8. Cloth

9. By Wound Type

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 9.1.2. Market Attractiveness Index, By Wound Type
  • 9.2. Chronic Wounds *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 9.2.3. Diabetic foot Ulcers
    • 9.2.4. Pressure Ulcers
    • 9.2.5. Venous Ulcers
    • 9.2.6. Others
  • 9.3. Acute Wounds
    • 9.3.1. Surgical wounds
    • 9.3.2. Traumatic wounds
    • 9.3.3. Burns

10. By End-User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.1.2. Market Attractiveness Index, By End-User
  • 10.2. Hospitals *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Specialty Clinics
  • 10.4. Research Organizations
  • 10.5. Trauma Centers
  • 10.6. Community Healthcare Centers
  • 10.7. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. UK
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Abbott Laboratories *
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. BioMerieux SA
  • 13.3. EKF Diagnostics Holdings plc
  • 13.4. Atlas Medical
  • 13.5. Quidel Corporation
  • 13.6. BIOSYNEX SA
  • 13.7. NG BIOTECH SAS
  • 13.8. Axis Medicare
  • 13.9. Cardinal Health Inc.
  • 13.10. Thermo Fisher Scientific Inc.

LIST NOT EXHAUSTIVE.

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us